Metabolic dysfunction and alcohol associated liver disease
MONDO:0957896A steatotic liver disease characterized by at least one of the five cardiometabolic risk factors for MASLD and alcohol consumption of 140-350g/week (females) or 210-420g/week (males). This disease is distinguished from MASLD by increased alcohol consumption and from ALD by the evidence of one or more of the MASLD cardiometabolic risk factors.
10 clinical trials for this condition and its sub-types, 8 tagged with Metabolic dysfunction and alcohol associated liver disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Liver scanner accuracy put to the test in new study
Knowledge-focused CompletedThis study looked at how consistent FibroScan, a non-invasive device that measures liver stiffness and fat, is when used by different operators on different days. 108 adults with fatty liver or alcohol-related liver disease had multiple scans and blood tests over two visits. The …
Sponsor: Echosens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Painless liver scan could spot hidden damage in heavy drinkers with extra weight
Knowledge-focused CompletedThis study tested whether adding a quick, painless liver scan (Fibroscan®) to standard screening questions could better identify people at risk for liver disease caused by both alcohol and excess weight. Fourteen English- or Spanish-speaking adults from underserved communities to…
Sponsor: Brown University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC